[go: up one dir, main page]

WO2006087717A3 - Non-immediate effects of therapy - Google Patents

Non-immediate effects of therapy Download PDF

Info

Publication number
WO2006087717A3
WO2006087717A3 PCT/IL2006/000204 IL2006000204W WO2006087717A3 WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3 IL 2006000204 W IL2006000204 W IL 2006000204W WO 2006087717 A3 WO2006087717 A3 WO 2006087717A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
immediate effects
patient
metabolic condition
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2006/000204
Other languages
French (fr)
Other versions
WO2006087717A2 (en
Inventor
Benny Rousso
Tamar Harel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metacure NV
Original Assignee
Metacure NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2005/000316 external-priority patent/WO2005087310A2/en
Priority claimed from PCT/US2005/044557 external-priority patent/WO2006073671A1/en
Priority to EP06711186.4A priority Critical patent/EP1868679B1/en
Priority to US11/884,389 priority patent/US9101765B2/en
Application filed by Metacure NV filed Critical Metacure NV
Priority to PCT/US2006/017281 priority patent/WO2006119467A2/en
Priority to EP06759102.4A priority patent/EP1898991B1/en
Priority to US11/919,491 priority patent/US8548583B2/en
Publication of WO2006087717A2 publication Critical patent/WO2006087717A2/en
Publication of WO2006087717A3 publication Critical patent/WO2006087717A3/en
Priority to US11/802,685 priority patent/US8352031B2/en
Anticipated expiration legal-status Critical
Priority to US13/970,647 priority patent/US8977353B2/en
Priority to US14/641,480 priority patent/US9440080B2/en
Priority to US14/821,848 priority patent/US9821158B2/en
Priority to US15/249,506 priority patent/US10352948B2/en
Priority to US16/232,088 priority patent/US20190137513A1/en
Priority to US17/524,015 priority patent/US11779768B2/en
Priority to US18/377,857 priority patent/US12268882B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4519—Muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37205—Microstimulators, e.g. implantable through a cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37288—Communication to several implantable medical devices within one patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Emergency Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method of treating a metabolic condition in a patient, comprising: determining a target non-immediate effect of a therapy relating to treatment of a metabolic condition; and applying an electric field to an abdominal cavity of the patient in a manner designed to at least approach said target.
PCT/IL2006/000204 1999-03-05 2006-02-16 Non-immediate effects of therapy Ceased WO2006087717A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
EP06711186.4A EP1868679B1 (en) 2005-02-17 2006-02-16 Non-immediate effects of therapy
US11/884,389 US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
PCT/US2006/017281 WO2006119467A2 (en) 2005-05-04 2006-05-04 Protein activity modification
EP06759102.4A EP1898991B1 (en) 2005-05-04 2006-05-04 Protein activity modification
US11/919,491 US8548583B2 (en) 2004-03-10 2006-05-04 Protein activity modification
US11/802,685 US8352031B2 (en) 2004-03-10 2007-05-24 Protein activity modification
US13/970,647 US8977353B2 (en) 2004-03-10 2013-08-20 Protein activity modification
US14/641,480 US9440080B2 (en) 2004-03-10 2015-03-09 Protein activity modification
US14/821,848 US9821158B2 (en) 2005-02-17 2015-08-10 Non-immediate effects of therapy
US15/249,506 US10352948B2 (en) 2004-03-10 2016-08-29 Protein activity modification
US16/232,088 US20190137513A1 (en) 2004-03-10 2018-12-26 Protein activity modification
US17/524,015 US11779768B2 (en) 2004-03-10 2021-11-11 Protein activity modification
US18/377,857 US12268882B2 (en) 2004-12-09 2023-10-09 Beta blocker therapy with electrical administration

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US65405605P 2005-02-17 2005-02-17
US60/654,056 2005-02-17
ILPCT/IL2005/000316 2005-03-18
PCT/IL2005/000316 WO2005087310A2 (en) 2004-03-18 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US67776105P 2005-05-04 2005-05-04
US60/677,761 2005-05-04
US71942105P 2005-09-22 2005-09-22
US71951705P 2005-09-22 2005-09-22
US60/719,517 2005-09-22
US60/719,421 2005-09-22
USPCT/US2005/044557 2005-12-09
PCT/US2005/044557 WO2006073671A1 (en) 2004-12-09 2005-12-09 Protein activity modification

Related Parent Applications (5)

Application Number Title Priority Date Filing Date
US10/497,126 Continuation-In-Part US20070060812A1 (en) 2001-11-29 2002-10-24 Sensing of pancreatic electrical activity
PCT/IL2002/000856 Continuation-In-Part WO2003045493A2 (en) 1999-03-05 2002-10-24 Sensing of pancreatic electrical activity
PCT/IL2004/000797 Continuation-In-Part WO2005023081A2 (en) 1999-03-05 2004-09-05 Blood glucose level control
PCT/IL2005/000316 Continuation-In-Part WO2005087310A2 (en) 1999-03-05 2005-03-18 Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
PCT/US2005/044557 Continuation-In-Part WO2006073671A1 (en) 1999-03-05 2005-12-09 Protein activity modification

Related Child Applications (6)

Application Number Title Priority Date Filing Date
US11/884,389 A-371-Of-International US9101765B2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy
US11/919,491 Continuation US8548583B2 (en) 2004-03-10 2006-05-04 Protein activity modification
PCT/US2006/017281 Continuation WO2006119467A2 (en) 2004-03-10 2006-05-04 Protein activity modification
PCT/US2006/017281 Continuation-In-Part WO2006119467A2 (en) 2004-03-10 2006-05-04 Protein activity modification
US11/802,685 Continuation US8352031B2 (en) 2004-03-10 2007-05-24 Protein activity modification
US14/821,848 Division US9821158B2 (en) 2005-02-17 2015-08-10 Non-immediate effects of therapy

Publications (2)

Publication Number Publication Date
WO2006087717A2 WO2006087717A2 (en) 2006-08-24
WO2006087717A3 true WO2006087717A3 (en) 2006-12-14

Family

ID=36916849

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000204 Ceased WO2006087717A2 (en) 1999-03-05 2006-02-16 Non-immediate effects of therapy

Country Status (2)

Country Link
EP (1) EP1868679B1 (en)
WO (1) WO2006087717A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
WO2006073671A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
EP1861160B1 (en) 2005-03-24 2011-11-16 Metacure Limited Wireless leads for gastrointestinal tract applications
US9233075B2 (en) 2005-08-09 2016-01-12 Metacure Limited Satiety
EP2150308B1 (en) 2007-05-09 2018-08-08 MetaCure Limited Analysis and regulation of food intake
MX2013006546A (en) * 2010-12-17 2013-09-05 Neural Diabetes Llc Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production.
US12053630B2 (en) 2014-08-17 2024-08-06 Coloplast A/S Implantable pulse generator with automatic jump-start
WO2016028608A1 (en) 2014-08-17 2016-02-25 Nine Continents Medical, Inc. Miniature implatable neurostimulator system for sciatic nerves and their branches
AU2023280320A1 (en) * 2022-06-01 2025-01-09 Dexcom, Inc. Systems and methods for monitoring, diagnosis, and decision support for diabetes in patients with kidney disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6895278B1 (en) * 1999-04-14 2005-05-17 Transneuronix, Inc. Gastric stimulator apparatus and method for use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1868679A4 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958872B2 (en) 1996-01-08 2015-02-17 Impulse Dynamics, N.V. Electrical muscle controller
US9186514B2 (en) 1996-01-08 2015-11-17 Impulse Dynamics Nv Electrical muscle controller
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9265930B2 (en) 1997-07-16 2016-02-23 Metacure Limited Methods and devices for modifying vascular parameters
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8977353B2 (en) 2004-03-10 2015-03-10 Impulse Dynamics Nv Protein activity modification
US9440080B2 (en) 2004-03-10 2016-09-13 Impulse Dynamics Nv Protein activity modification
US9339190B2 (en) 2005-02-17 2016-05-17 Metacure Limited Charger with data transfer capabilities
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy

Also Published As

Publication number Publication date
EP1868679A2 (en) 2007-12-26
WO2006087717A2 (en) 2006-08-24
EP1868679A4 (en) 2012-10-24
EP1868679B1 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
WO2006087717A3 (en) Non-immediate effects of therapy
EP3150204A3 (en) Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
WO2008127373A3 (en) Methods and devices for treating tissue
WO2006119467A3 (en) Protein activity modification
WO2004064728A3 (en) Use of specific tetracycline compounds in therapy
WO2006113802A3 (en) Device for administering electrode stimulation of back and abdominal muscles
WO2008016922A3 (en) Peri-capsular fibroid treatment
GB0518219D0 (en) Improvements in or relating to cryogenic therapeutic treatments
WO2005096990A3 (en) Novel modification of medical prostheses
WO2010044879A3 (en) Method and devices for self adjusting phototherapeutic intervention
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2009079451A3 (en) Compositions and methods of promoting wound healing
WO2009031606A1 (en) Therapeutic and prophylactic agents for arthritis
CY1110182T1 (en) IDEENONON FOR THE TREATMENT OF MUSCLE DYSTROPHY
WO2006099610A3 (en) Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
WO2006073671A8 (en) Protein activity modification
WO2007100728A3 (en) Mannose derivatives for killing tumor cells
WO2007006012A3 (en) Methods for reducing pathogens in biological samples
WO2009043022A3 (en) Individualized cancer treatments
WO2007028123A3 (en) Cochlear implant fitting
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
WO2007064900A3 (en) Treatment of lesions or imperfections in mammalian skin or near-skin tissues or in or near other anatomic surfaces
WO2009106555A3 (en) Sterilized sucralfate gel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11802685

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 11884389

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2006711186

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006711186

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11802685

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006711186

Country of ref document: EP